Biotechnology

This function is exclusive for Premium subscribers

  • DATABASE (121)

  • ARTICLES (104)

    • DATABASE (121)
    • ARTICLES (104)

Besides helping medics to spot Covid-19 symptoms, BioMind is gearing up to launch its first EU-certified AI-powered diagnostic system for neurological diseases.

East Ventures-backed microbiome personalized skincare firm is also known for helping produce Indonesia's first Covid-19 test kit, as part of state R&D collaboration.

Krakakoa empowers and supports farmers to become master craftsmen in their trade, creating the exceptional cacao beans that go into our chocolate.

Digital health startup offering genotyping tests and analysis using AI for personal cardiovascular, pharmaco and wellness (diet and fitness) genetics-based predictions and health guidelines.

A one-stop shop solution for replanting deforested areas is currently Spain's most talked-about startup. 

Grow your own Bioo “plant electricity” and portable Bioo Wi-Fi for home devices and smartphones.

Formerly known as Guangdong Technology Venture Capital Group, Technology Financial Group is a state-owned firm based in Guangzhou. It has a subsidiary in Guangdong province and has set up nine offices in other provinces across China. Technology Financial Group began investing in companies when it was founded in 1992, and it has assets under management of RMB 50bn. With a focus on VC investment, it also provides financial services such as asset management.The firm invests mainly in the high-end equipment manufacturing; new-generation information technology; new material; art, entertainment and media; consumption; biotech and pharmacy; energy and environmental protection; and automotive sectors.

Established in 1995 by Sean O'Sullivan, SOSV is a venture capital firm with six attached accelerator programs. Upon receiving investment from SOSV, portfolio companies join one of the accelerator programs that best suits their products. The accelerators are: Chinaccelerator, focused on the Chinese market; Indie Bio, supporting biotechnology and life sciences companies; Food-X, for food-tech and agriculture-focused companies; dlab, which supports startups exploring blockchain and decentralized tech; HAX, for IoT, robotics and other hardware-focused startups; and MOX, an accelerator specializing in mobile platforms and technologies. SOSV, along with the O'Sullivan Foundation, has also provided support for education initiatives such as Khan Academy and CoderDojo (which teaches coding skills to youth).

Headquartered in Shanghai, FC Capital was founded in 2017 to focus on investments in China and the US. The VC mainly invests in medtech sectors like biotechnology, medical devices, medical services and health-related consumer products.

Baiyang Capital was founded in 2014 by BAHEAL Pharmaceutical Holdings Limited and several senior professionals in the pharmaceutical and healthcare fields. The investment management company operates multiple funds, targeting pharmaceutical and healthcare businesses.

Founded in 2002, Bluesail was initially known as a manufacturer of PVC gloves, with an annual capacity of tens of billions of pairs at its peak. At the end of 2012, it began to expand into more health-related areas.In 2018, it acquired a 93.37% stake in Biosensors International Group that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The two companies were merged and Bluesail began to produce more high-end medical consumables. In 2019, the company and senior executives invested in CH Biomedical to collaborate in the development of innovative medical devices for sale in China and overseas. 

Established in September 2016, Chobe Capital is based in Shanghai. The firm is a registered private equity manager, focusing on pre-IPO and VC projects. Chobe Capital mainly invests in various sectors like TMT, biotechnology, consumer products and environmental protection.

Launched in 2017 by the Mobile World Capital Barcelona, The Collider is a new venture builder that brings together scientists and entrepreneurs to carry out scientific and technological projects through highly innovative startups. It aims to foster the adoption and implementation of new technologies in the field of AI, IoT, Blockchain, VR and 5G networks to facilitate technological transitions and innovations through science and deep-tech knowledge.

Dayli Partners is a VC company in South Korea that specializes in biotech and healthcare investments. It is a partner of Korea's TIPS (Tech Incubator Program for Startups) initiative, which aims to find the best startups in the country and help them develop their potential. As of December 2019, it has an AUM total of $170.7m and aims to manage $350m in assets by the end of 2020.

B Capital Group is best known as the venture capital firm co-founded by Eduardo Saverin, co-founder of Facebook. Its investment thesis focuses on connecting highly innovative and agile startups with major corporates that are in need of innovation and have the resources to innovate. As such, B Capital has a special interest in B2B companies that have great potential to disrupt critical industries. This includes startups that are disrupting healthcare and biotechnology, as well as finance and insurance. B Capital has also supported some notable B2C companies, including coffee chain Kopi Kenangan and used car marketplace Carro.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.